Shen K Robert, Wain John C, Wright Cameron D, Grillo Hermes C, Mathisen Douglas J
General Thoracic Surgery Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
J Thorac Cardiovasc Surg. 2008 Jun;135(6):1210-6; discussion 1216-9. doi: 10.1016/j.jtcvs.2007.11.022.
Postpneumonectomy syndrome is a rare syndrome of dynamic airway obstruction caused by extreme rotation and shift of the mediastinum after pneumonectomy, resulting in symptomatic central airway compression. We have treated this syndrome by mediastinal repositioning and placement of saline-filled prostheses into the pneumonectomy space. There is a paucity of outcome data for patients treated surgically, with only a single series of 11 patients previously reported. We analyzed our recent experience with treatment of this syndrome and report on the short and long-term outcomes and quality of life assessment of the largest series ever reported of patients treated by mediastinal repositioning.
Records were reviewed of all patients who underwent mediastinal repositioning for postpneumonectomy syndrome between January of 1992 and June of 2006. Long-term health-related quality of life was assessed by administration of the Saint George's Respiratory Questionnaire.
There were 18 patients (15 women and 3 men) with a median age of 44 years (range 14-67 years). Thirteen patients had undergone right pneumonectomy, and 5 patients had undergone left pneumonectomy. None of the patients in whom postpneumonectomy syndrome developed after left pneumonectomy had a right-sided aortic arch. Five patients had undergone pneumonectomy in childhood (age < 13 years). The median interval between pneumonectomy and mediastinal repositioning was 7.5 years (range 1.1-54.8 years). The median follow-up was 32 months (range 4-143 months). The operative mortality was 5.6% (1/18). Complications occurred in 5 patients (27.8%): pneumonia in 3 patients and acute respiratory distress syndrome in 2 patients. The median hospitalization was 6 days (range 3-155 days). Some 77% (10/13) of patients reported significant improvement in their breathing and overall state of health after surgery; 15.4% of patients (2/13) were somewhat better, and 7.7% of patients (1/13) had no improvement. No patients' condition was worse after surgery. All patients who reported improvement in their symptoms after surgery remained symptomatically improved at the time of the quality of life assessment. Some 92.3% (12/13) were not at all or only slightly limited in their social activities because of breathing problems, and 84.6% (11/13) were not at all or only slightly limited in their ability to work as a result of their physical health.
Repositioning of the mediastinum with placement of prostheses for postpneumonectomy syndrome can be performed with low mortality and morbidity. Surgical repositioning provides immediate and lasting symptomatic relief to patients in whom postpneumonectomy syndrome develops.
肺切除术后综合征是一种罕见的动态气道梗阻综合征,由肺切除术后纵隔的极度旋转和移位引起,导致有症状的中央气道受压。我们通过纵隔复位并在肺切除空间内放置盐水填充假体来治疗该综合征。手术治疗患者的预后数据较少,此前仅报道过一组11例患者的病例系列。我们分析了近期治疗该综合征的经验,并报告了纵隔复位治疗患者有史以来最大病例系列的短期和长期预后以及生活质量评估情况。
回顾了1992年1月至2006年6月期间因肺切除术后综合征接受纵隔复位的所有患者的记录。通过使用圣乔治呼吸问卷评估与健康相关的长期生活质量。
共有18例患者(15例女性和3例男性),中位年龄为44岁(范围14 - 67岁)。13例患者接受了右肺切除术,5例患者接受了左肺切除术。左肺切除术后发生肺切除术后综合征的患者中,无一例有右侧主动脉弓。5例患者在儿童期(年龄<13岁)接受了肺切除术。肺切除与纵隔复位之间的中位间隔时间为7.5年(范围1.1 - 54.8年)。中位随访时间为32个月(范围4 - 143个月)。手术死亡率为5.6%(1/18)。5例患者(27.8%)出现并发症:3例患者发生肺炎,2例患者发生急性呼吸窘迫综合征。中位住院时间为6天(范围3 - 至155天)。约77%(10/13)的患者报告术后呼吸和整体健康状况有显著改善;15.4%的患者(2/13)有所好转,7.7%的患者(1/13)无改善。术后没有患者的病情恶化。所有报告术后症状改善的患者在生活质量评估时症状仍持续改善。约92.3%(12/13)的患者因呼吸问题在社交活动中完全或仅略有受限,84.6%(11/13)的患者因身体健康在工作能力方面完全或仅略有受限。
通过放置假体进行纵隔复位治疗肺切除术后综合征,手术死亡率和发病率较低。手术复位能为发生肺切除术后综合征的患者提供即时且持久的症状缓解。